List of insiders holdings for Principia Biopharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
2020-08-25 12:32:36 | 5,231,900 0 |
5,231,900 | Form 13D |
| 2 | Thompson Peter A. Director |
2018-09-13 17:14:12 | 3,945 2,384,336 |
2,388,281 | Form 3 |
| 3 | USMAN NASSIM Director 10% Owner |
2018-09-13 17:12:38 | 0 2,223,748 |
2,223,748 | Form 3 |
| 4 | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2020-02-14 16:14:32 | 1,808,684 0 |
1,808,684 | Form 13G |
| 5 | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner |
2020-02-13 13:22:07 | 1,438,196 0 |
1,438,196 | Form 13G |
| 6 | New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner |
2020-02-12 17:38:03 | 943,248 0 |
943,248 | Form 13G |
| 7 | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner |
2019-12-13 16:32:17 | 288,119 0 |
288,119 | Form 13G |
| 8 | Gourlay Steve Chief Medical Officer |
2018-09-20 18:47:05 | 108,482 0 |
108,482 | Form 4 |
| 9 | Shuster Lewis Director |
2019-01-10 21:53:14 | 20,475 0 |
20,475 | Form 4 |
| 10 | Smither John W Director |
2019-02-21 18:07:08 | 20,475 0 |
20,475 | Form 4 |
| 11 | AKKARAJU SRINIVAS Director |
2019-01-10 21:40:30 | 20,475 0 |
20,475 | Form 4 |
| 12 | Tomasello Shawn Director |
2020-09-28 17:29:51 | 0 0 |
0 | Form 4 |
| 13 | Machado Patrick Director |
2020-09-28 17:28:51 | 0 0 |
0 | Form 4 |
| 14 | George Simeon Director |
2020-09-28 17:27:23 | 0 0 |
0 | Form 4 |
| 15 | Lin Shao-Lee Director |
2020-09-28 17:25:45 | 0 0 |
0 | Form 4 |
| 16 | Becker Daniel J. Director |
2020-09-28 17:24:20 | 0 0 |
0 | Form 4 |
| 17 | Colowick Alan Director |
2020-09-28 17:21:15 | 0 0 |
0 | Form 4 |
| 18 | Wolff Stefani Chief Development Officer |
2020-09-28 17:19:26 | 0 0 |
0 | Form 4 |
| 19 | Thomas Dolca Chief Medical Officer |
2020-09-28 17:16:30 | 0 0 |
0 | Form 4 |
| 20 | Hardiman Roy C. Chief Business Officer |
2020-09-28 17:14:32 | 0 0 |
0 | Form 4 |
| 21 | CHAI CHRISTOPHER Y Chief Financial Officer |
2020-09-28 17:11:14 | 0 0 |
0 | Form 4 |
| 22 | Goldstein David M Chief Scientific Officer |
2020-09-28 17:08:55 | 0 0 |
0 | Form 4 |
| 23 | Babler Martin President, CEO |
2020-09-28 17:07:12 | 0 0 |
0 | Form 4 |
| 24 | GLAXOSMITHKLINE PLC Former 10% Owner |
2020-09-30 21:00:32 | 0 0 |
0 | Form 13D |
| 25 | MORGENTHALER VENTURE PARTNERS IX LP Morgenthaler Management Partners IX LLC 10% Owner |
2020-02-10 21:01:31 | 0 0 |
0 | Form 13G |